The current valuation score of Phathom Pharmaceuticals Inc is 8.43, ranking 88 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -5.20, which is -91.50% below the recent high of -0.44 and -19.94% above the recent low of -6.23.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.